📰 Human Use News

Page 141 - Human Use News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.

ObsEva Announces First Quarter 2022 Financial Results and Provides Corporate Update

May 18, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United States Shauna Dillon Brandi Howard Yuyuan Bioscience Technology European Commission Drug Administration

Source: apnews.com

Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma With Updated Data From BCMA CAR-T Studies at 2022 ASCO and EHA

May 18, 2022

Longer term follow-up data will be presented from the pivotal CARTITUDE-1 study in patients with relapsed or refractory multiple myeloma, which supported the recent U.S. FDA approval of CARVYKTI

United States New Jersey Ciltacabtagene Autoleucel Hemophagocytic Lymphohistiocytosis Joanne Choi Ying Huang

Source: finanznachrichten.de

ObsEva SA: ObsEva Announces First Quarter 2022 Financial Results and Provides Corporate Update

May 17, 2022

-Linzagolix for uterine fibroids: Received confirmation of positive CHMP opinion for marketing authorization application; United States NDA PDUFA date in Q3:22- -Linzagolix for endometriosis:

United States Shauna Dillon Brandi Howard Brian Ocallaghan Yuyuan Bioscience Technology European Commission

Source: finanznachrichten.de

Investegate |ObsEva SA Announcements | ObsEva SA: ObsEva Announces First Quarter 2022 Financial Results and Provides Corporate Update

May 17, 2022

Investegate announcements from ObsEva SA, ObsEva Announces First Quarter 2022 Financial Results and Provides Corporate Update

United States Shauna Dillon Brandi Howard Yuyuan Bioscience Technology European Commission Drug Administration

Source: investegate.co.uk

NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2022 - Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Progressing Further for Clinical Trials Application

May 17, 2022

SHELTON, CT / ACCESSWIRE / May 17, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines

United States Nanoviricides Inc Drug Administration Company Form Exchange Commission Committee For Medicinal Products Human

Source: finanznachrichten.de

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline

May 16, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United States Travis Mickle Jason Rando Daniel Kontoh Boateng Marc Patterson Richard Pascoe Canaccord Genuity

Source: apnews.com

Valneva Receives Notice of European Commission's Intent to Terminate COVID-19 Vaccine Purchase Agreement

May 16, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United Arab Emirates Joshua Drumm Thomas Lingelbach National Health Regulatory Authority Vp Global Communications European Investor Relations European Medicines Agency

Source: apnews.com

Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results

May 12, 2022

Press release content from Business Wire. The AP news staff was not involved in its creation.

United States Sasha Damouni Ellis Scott Braunstein Corporate Affairs Investor Relations Orion Corporation Marinus Pharmaceuticals

Source: apnews.com

Biohaven Reports First Quarter 2022 Financial Results and Reports Recent Business Developments

May 10, 2022

Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. today announced that the companies have entered into a definitive agreement under which Pfizer...

New York United States United Kingdom South Korea City Of Irina Antonijevic

Source: prnewswire.com